Dassault Systèmes combines a 29% PLM market share, 81% recurring software revenue, and deep de-rating with catalysts capable of restoring double-digit growth.
Overview
Dassault Systèmes is a global enterprise software company built around 3D design, simulation, product lifecycle management, digital twins, and clinical technology. Its 3DEXPERIENCE platform serves eleven industrial sectors, while recurring subscription and support revenue represented approximately 81% of Q2 2026 software revenue, creating visibility and predictable cash generation. The company retains a wide moat through CATIA and ENOVIA switching costs, ecosystem lock-in across industrial supply chains, and scientific and clinical intellectual property, including Medidata data from more than 10 million patients across over 34,000 clinical trials. Q2 2026 revenue rose 4% constant-currency to EUR 1.556 billion, non-IFRS diluted EPS increased 8% constant-currency to EUR 0.31, and operating margin expanded to 30.0%. Management reaffirmed 2026 revenue guidance of EUR 6.296–6.416 billion and targets EUR 2.40 non-IFRS EPS by 2029. **The stock has de-rated to roughly 15.0x expected 2026 EPS from a 92.9x 2021 peak**, despite recurring revenue and cash-flow strength. The principal near-term catalysts are ArisGlobal integration, Life Sciences recovery, AI monetization, and aerospace and defense spending; automotive weakness and execution risk explain the cautious Hold consensus.